RedHill Biopharma Ltd (RDHL)

[midastouch017]

RedHill Biopharma falls 4% amid H. pylori drug Talicia addition to California's Medi-Cal

Oct. 06, 2021 10:23 AM ETRedHill Biopharma Ltd. (RDHL)

By: Ravikash, SA News Editor1 Comment

RedHill Biopharma (RDHL -3.6%) said California's Medicaid Health Care program Medi-Cal added Talicia to its Contract Drug List (CDL) for H. pylori treatment, with no prior authorization required, effective Oct. 1.
"Medi-Cal's addition of Talicia with no prior authorization required is an important step in Talicia's continuing growth and we are pleased that it will be made available to Medi-Cal's 2 million FFS lives," said RedHill CFO Rick Scruggs.
"There is growing recognition of the need to employ effective, first-line therapy against H. pylori infections that does not rely on clarithromycin and that patients can tolerate well and adhere to over 14 days of therapy. Talicia meets those criteria," added Scruggs.